Pyrophosphorolytic excision of nonobligate chain terminators by hepatitis C virus NS5B polymerase

被引:33
作者
Deval, Jerome
Powdrill, Megan H.
D'Abramo, Claudia M.
Cellai, Luciano
Gotte, Matthias
机构
[1] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada
[2] McGill Univ, Dept Med, Montreal, PQ H3A 2B4, Canada
[3] McGill Univ, Dept Biochem, Montreal, PQ H3A 2B4, Canada
[4] CNR, Ist Cristallog, Sede Roma, Rome, Italy
关键词
D O I
10.1128/AAC.00186-07
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Nonobligate chain terminators, such as 2'-C-methylated nucleotides, block RNA synthesis by the RNAdependent RNA polymerase (RdRp) of hepatitis C virus (HCV). Previous studies with related viral polymerases have shown that classical chain terminators lacking the Y-hydroxyl group can be excised in the presence of pyrophosphate (PPi), which is detrimental to the inhibitory activity of these compounds. Here we demonstrate that the HCV RdRp enzyme is capable of removing both obligate and clinically relevant nonobligate chain terminators. Pyrimidines are more efficiently excised than are purines. The presence of the next complementary templated nucleotide literally blocks the excision of obligate chain terminators through the formation of a dead-end complex (DEC). However, 2'-C-methylated CMP is still cleaved efficiently under these conditions. These findings show that a T-methylated primer terminus impedes nucleotide binding. The S282T mutation, associated with resistance to 2'-C-methylated nucleotides, does not affect the excision patterns. Thus, the decreased susceptibility to 2'-C-methylated nucleotides appears to be based solely on improved discrimination between the inhibitor and its natural counterpart. In conclusion, our data suggest that the phosphorolytic excision of nonobligate, pyrimidine-based chain terminators can diminish their potency. The templated nucleotide does not appear to provide protection from excision through DEC formation.
引用
收藏
页码:2920 / 2928
页数:9
相关论文
共 45 条
[1]   Cell-free replication of the hepatitis C virus subgenomic replicon [J].
Ali, N ;
Tardif, KD ;
Siddiqui, A .
JOURNAL OF VIROLOGY, 2002, 76 (23) :12001-12007
[2]   Recovery, persistence, and sequelae in hepatitis C virus infection: A perspective on long-term outcome [J].
Alter, HJ ;
Seeff, LB .
SEMINARS IN LIVER DISEASE, 2000, 20 (01) :17-35
[3]   Phenotypic mechanism of HIV-1 resistance to 3′-azido-3′-deoxythymidine (AZT):: Increased polymerization processivity and enhanced sensitivity to pyrophosphate of the mutant viral reverse transcriptase [J].
Arion, D ;
Kaushik, N ;
McCormick, S ;
Borkow, G ;
Parniak, MA .
BIOCHEMISTRY, 1998, 37 (45) :15908-15917
[4]   Crystal structures of the RNA-dependent RNA polymerase genotype 2a of hepatitis C virus reveal two conformations and suggest mechanisms of inhibition by non-nucleoside inhibitors [J].
Biswal, BK ;
Cherney, MM ;
Wang, MT ;
Chan, L ;
Yannopoulos, CG ;
Bilimoria, D ;
Nicolas, O ;
Bedard, J ;
James, MNG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (18) :18202-18210
[5]   Inhibition of hepatitis C virus RNA replication by 2′-modified nucleoside analogs [J].
Carroll, SS ;
Tomassini, JE ;
Bosserman, M ;
Getty, K ;
Stahlhut, MW ;
Eldrup, AB ;
Bhat, B ;
Hall, D ;
Simcoe, AL ;
LaFemina, R ;
Rutkowski, CA ;
Wolanski, B ;
Yang, ZC ;
Migliaccio, G ;
De Francesco, R ;
Kuo, LC ;
MacCoss, M ;
Olsen, DB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (14) :11979-11984
[6]   Excision of incorporated nucleotide analogue chain-terminators can diminish their inhibitory effects on viral RNA-dependent RNA polymerases [J].
D'Abramo, CM ;
Cellai, L ;
Götte, M .
JOURNAL OF MOLECULAR BIOLOGY, 2004, 337 (01) :1-14
[7]   Challenges and successes in developing new therapies for hepatitis C [J].
De Francesco, R ;
Migliaccio, G .
NATURE, 2005, 436 (7053) :953-960
[8]   Structural determinants and molecular mechanisms for the resistance of HIV-1 RT to nucleoside analogues [J].
Deval, J ;
Courcambeck, J ;
Selmi, B ;
Boretto, J ;
Canard, B .
CURRENT DRUG METABOLISM, 2004, 5 (04) :305-316
[9]   Interdomain communication in hepatitis C virus polymerase abolished by small molecule inhibitors bound to a novel allosteric site [J].
Di Marco, S ;
Volpari, C ;
Tomei, L ;
Altamura, S ;
Harper, S ;
Narjes, F ;
Koch, U ;
Rowley, M ;
De Francesco, R ;
Migliaccio, G ;
Carfí, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (33) :29765-29770
[10]   A relaxed discrimination of 2′-O-methyl-GTP relative to GTP between de novo and elongative RNA synthesis by the hepatitis c RNA-dependent RNA polymerase NS5B [J].
Dutartre, H ;
Boretto, J ;
Guillemot, JC ;
Canard, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (08) :6359-6368